Variant report

Variant	nsv964100
Chromosome Location	chr4:144268743-144271466
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:102)
CpG islands
(count:123)
Chromatin interactive
region (count:4)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:102 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:144269570-144269910	K562	blood:	n/a	n/a
2	BHLHE40	chr4:144269642-144269929	K562	blood:	n/a	n/a
3	CBX3	chr4:144269468-144270132	K562	blood:	n/a	n/a
4	CCNT2	chr4:144269643-144269981	K562	blood:	n/a	n/a
5	CEBPB	chr4:144269484-144269910	K562	blood:	n/a	n/a
6	CEBPB	chr4:144268746-144269920	K562	blood:	n/a	n/a
7	CEBPD	chr4:144269476-144270090	K562	blood:	n/a	n/a
8	CEBPD	chr4:144269459-144270048	K562	blood:	n/a	n/a
9	CTCF	chr4:144269780-144269872	K562	blood:	n/a	n/a
10	CUX1	chr4:144269517-144269908	K562	blood:	n/a	n/a
11	EBF1	chr4:144268848-144268930	GM12878	blood:	n/a	n/a
12	EP300	chr4:144269683-144269910	K562	blood:	n/a	n/a
13	EP300	chr4:144268951-144269956	K562	blood:	n/a	chr4:144269009-144269023 chr4:144269048-144269058 chr4:144269058-144269072
14	FOXA1	chr4:144268812-144269215	HepG2	liver:	n/a	n/a
15	FOXA1	chr4:144269409-144269662	T-47D	breast:	n/a	n/a
16	FOXA1	chr4:144268878-144269140	T-47D	breast:	n/a	n/a
17	FOXA1	chr4:144268838-144269227	T-47D	breast:	n/a	n/a
18	FOXA2	chr4:144268962-144269178	HepG2	liver:	n/a	n/a
19	GATA1	chr4:144271273-144271663	PBDE	blood:	n/a	n/a
20	GATA1	chr4:144269540-144269964	PBDEFetal	blood:	n/a	n/a
21	GATA1	chr4:144268842-144270327	K562	blood:	n/a	n/a
22	GATA1	chr4:144269131-144270184	PBDE	blood:	n/a	n/a
23	GATA2	chr4:144269370-144270143	K562	blood:	n/a	n/a
24	GATA2	chr4:144268970-144270286	SH-SY5Y	brain:	n/a	n/a
25	GATA2	chr4:144269393-144270051	K562	blood:	n/a	n/a
26	GATA3	chr4:144269373-144269703	SH-SY5Y	brain:	n/a	n/a
27	GATA3	chr4:144269204-144269909	SK-N-SH	brain:	n/a	n/a
28	GATA3	chr4:144269259-144269838	MCF-7	breast:	n/a	n/a
29	GATA3	chr4:144269296-144269766	T-47D	breast:	n/a	n/a
30	GATA3	chr4:144269314-144270093	T-47D	breast:	n/a	n/a
31	GATA3	chr4:144269324-144269923	MCF-7	breast:	n/a	n/a
32	GATA3	chr4:144269352-144269680	MCF-7	breast:	n/a	n/a
33	GATA3	chr4:144269357-144269849	MCF-7	breast:	n/a	n/a
34	HCFC1	chr4:144269403-144269850	K562	blood:	n/a	n/a
35	HDAC2	chr4:144269547-144269917	K562	blood:	n/a	n/a
36	HEY1	chr4:144271017-144271322	K562	blood:	n/a	n/a
37	HEY1	chr4:144270493-144270783	K562	blood:	n/a	n/a
38	HEY1	chr4:144270432-144271282	K562	blood:	n/a	n/a
39	IRF1	chr4:144269576-144269907	K562	blood:	n/a	n/a
40	JUND	chr4:144269495-144269944	K562	blood:	n/a	n/a
41	MAFF	chr4:144269773-144269809	K562	blood:	n/a	n/a
42	MAX	chr4:144269599-144270109	K562	blood:	n/a	n/a
43	MAX	chr4:144269750-144270012	K562	blood:	n/a	n/a
44	MAX	chr4:144269624-144270238	K562	blood:	n/a	n/a
45	MAZ	chr4:144269562-144270160	K562	blood:	n/a	n/a
46	MYC	chr4:144269504-144270100	K562	blood:	n/a	n/a
47	MYC	chr4:144269460-144270237	K562	blood:	n/a	n/a
48	NR2F2	chr4:144269437-144270035	K562	blood:	n/a	n/a
49	NR2F2	chr4:144269525-144269964	K562	blood:	n/a	n/a
50	PML	chr4:144269541-144269995	K562	blood:	n/a	n/a

(count:123 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:144271265-144271315	K562	blood:	n/a
2	chr4:144271265-144271315	K562	blood:	n/a
3	chr4:144270944-144270994	HRE	kidney:	n/a
4	chr4:144271265-144271315	GM06990	blood:	n/a
5	chr4:144271265-144271315	HepG2	liver:	n/a
6	chr4:144270944-144270994	HEK293	kidney:	embryo
7	chr4:144270944-144270994	SK-N-SH	brain:	n/a
8	chr4:144270944-144270994	NHDF-neo	bronchial:	n/a
9	chr4:144270944-144270994	Jurkat	blood:	n/a
10	chr4:144271265-144271315	Caco-2	colon:	n/a
11	chr4:144271265-144271315	HAEpiC	amniotic membrane:	n/a
12	chr4:144270944-144270994	HCF	heart:	n/a
13	chr4:144271265-144271315	NB4	blood:	n/a
14	chr4:144271265-144271315	RPTEC	kidney:	n/a
15	chr4:144271265-144271315	SAEC	small airway:	n/a
16	chr4:144271265-144271315	SKMC	muscle:	n/a
17	chr4:144270944-144270994	HAEpiC	amniotic membrane:	n/a
18	chr4:144270944-144270994	HCT-116	colon:	n/a
19	chr4:144270944-144270994	SK-N-MC	brain:	n/a
20	chr4:144270944-144270994	H1-hESC	embryonic stem cell:	embryo
21	chr4:144271265-144271315	AG04450	lung:	fetal
22	chr4:144270944-144270994	HUVEC	blood vessel:	n/a
23	chr4:144271265-144271315	GM12892	blood:	n/a
24	chr4:144270944-144270994	HIPEpiC	eye:	n/a
25	chr4:144270944-144270994	HCM	heart:	n/a
26	chr4:144270944-144270994	NHBE	bronchial:	n/a
27	chr4:144270944-144270994	AG09319	gingival:	n/a
28	chr4:144270944-144270994	GM12891	blood:	n/a
29	chr4:144270944-144270994	MCF-7	breast:	n/a
30	chr4:144271265-144271315	HPAEpiC	pulmonary alveolar:	n/a
31	chr4:144270944-144270994	LNCaP	prostate:	n/a
32	chr4:144271265-144271315	IMR90	lung:	fetal
33	chr4:144271265-144271315	AG10803	skin:	n/a
34	chr4:144270944-144270994	Hepatocyte	liver:	n/a
35	chr4:144271265-144271315	ProgFib	skin:	n/a
36	chr4:144270944-144270994	K562	blood:	n/a
37	chr4:144271265-144271315	HNPCEpiC	eye:	n/a
38	chr4:144270944-144270994	RPTEC	kidney:	n/a
39	chr4:144271265-144271315	T-47D	breast:	n/a
40	chr4:144271265-144271315	ECC-1	luminal epithelium:	n/a
41	chr4:144271265-144271315	Jurkat	blood:	n/a
42	chr4:144270944-144270994	GM19239	blood:	n/a
43	chr4:144270944-144270994	BJ	skin:	n/a
44	chr4:144271265-144271315	MCF-7	breast:	n/a
45	chr4:144271265-144271315	SK-N-MC	brain:	n/a
46	chr4:144270944-144270994	HepG2	liver:	n/a
47	chr4:144270944-144270994	PANC-1	pancreas:	n/a
48	chr4:144270944-144270994	HEEpiC	esophagus:	n/a
49	chr4:144271265-144271315	HCF	heart:	n/a
50	chr4:144271265-144271315	AG04449	skin:	fetal

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:144256119..144259388-chr4:144266158..144269819,4	MCF-7	breast:
2	chr4:144268435..144271097-chr4:144272609..144275318,3	K562	blood:
3	chr4:144263524..144266219-chr4:144271347..144273028,2	MCF-7	breast:
4	chr4:144267296..144268822-chr4:144271997..144274488,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000228981	TF binding region
ENSG00000228981	CpG island
ENSG00000178972	chromatin interactions
ENSG00000109458	chromatin interactions
ENSG00000265623	chromatin interactions

Extended variants
information (count: 108 )
Associated
traits (count: 71 )

Variant overlapped rSNPs/rCNVs (count:108 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs537284165	chr4:144268771-144268772	Weak transcription Enhancers Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs76751725	chr4:144268801-144268802	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs570880270	chr4:144268815-144268816	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs534972264	chr4:144268836-144268837	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs62337513	chr4:144268888-144268889	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs78252283	chr4:144268932-144268933	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs80071653	chr4:144268938-144268939	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs114063108	chr4:144268991-144268992	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs112923778	chr4:144269071-144269072	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs77064754	chr4:144269134-144269135	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs564139944	chr4:144269183-144269184	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs528174220	chr4:144269190-144269191	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs540183061	chr4:144269233-144269234	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs561527167	chr4:144269251-144269252	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs80194956	chr4:144269269-144269270	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs570030894	chr4:144269290-144269291	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs566168916	chr4:144269296-144269297	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs138770033	chr4:144269340-144269341	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs190379937	chr4:144269341-144269342	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs570885030	chr4:144269405-144269406	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs181175603	chr4:144269556-144269557	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs140369293	chr4:144269626-144269627	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs111722352	chr4:144269642-144269643	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs535884681	chr4:144269661-144269662	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs557257168	chr4:144269739-144269740	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs371226420	chr4:144269751-144269752	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs147978571	chr4:144269764-144269765	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs557674377	chr4:144269795-144269796	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs6833103	chr4:144269807-144269808	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs141705884	chr4:144269842-144269843	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
31	rs300917	chr4:144269849-144269850	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
32	rs185388111	chr4:144269852-144269853	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
33	rs545746802	chr4:144269863-144269864	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
34	rs564241246	chr4:144269866-144269867	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
35	rs368779004	chr4:144269868-144269869	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
36	rs150529730	chr4:144269901-144269902	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
37	rs563594921	chr4:144269931-144269932	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
38	rs189707318	chr4:144269932-144269933	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
39	rs372384219	chr4:144269955-144269956	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
40	rs552493154	chr4:144269968-144269969	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
41	rs184077871	chr4:144269981-144269982	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
42	rs138705392	chr4:144270027-144270028	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
43	rs576259485	chr4:144270052-144270053	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
44	rs144018836	chr4:144270054-144270055	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
45	rs568554133	chr4:144270055-144270056	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
46	rs188970376	chr4:144270063-144270064	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
47	rs543335303	chr4:144270091-144270092	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
48	rs550995018	chr4:144270104-144270105	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
49	rs561586715	chr4:144270114-144270115	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
50	rs569129476	chr4:144270130-144270131	Weak transcription Enhancers Genic enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:71)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	21183584	CNVD
primary effusion lymphomas	17116491	CNVD
Breast cancer	16272173	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	17133270	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Esophageal cancer	21851588	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Olfactory neuroblastoma	18408657	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Mental retardation	17901693	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Myelofibrosis	22110671	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Breast cancer	22048815	CNVD
Autism	22241247	CNVD
Glioblastoma multiforme	22286061	CNVD

Chromatin state (count:213 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:144259200-144272400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr4:144259400-144272000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
3	chr4:144259400-144272600	Weak transcription	H1 Cell Line	embryonic stem cell
4	chr4:144259600-144276200	Weak transcription	Fetal Kidney	kidney
5	chr4:144260000-144272800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
6	chr4:144261600-144272600	Weak transcription	Adipose Nuclei	Adipose
7	chr4:144263000-144276600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
8	chr4:144263000-144277800	Weak transcription	Fetal Thymus	thymus
9	chr4:144264000-144270200	Enhancers	Rectal Smooth Muscle	rectum
10	chr4:144264000-144276400	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
11	chr4:144264200-144269600	Enhancers	Duodenum Smooth Muscle	Duodenum
12	chr4:144264600-144269800	Enhancers	Fetal Intestine Small	intestine
13	chr4:144264600-144270000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
14	chr4:144264800-144269400	Weak transcription	Colonic Mucosa	Colon
15	chr4:144265000-144270000	Enhancers	Colon Smooth Muscle	Colon
16	chr4:144265400-144268800	Enhancers	HepG2	liver
17	chr4:144265600-144269200	Weak transcription	Fetal Muscle Leg	muscle
18	chr4:144265600-144269600	Weak transcription	Lung	lung
19	chr4:144265600-144270000	Enhancers	Skeletal Muscle Male	skeletal muscle
20	chr4:144265600-144270200	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
21	chr4:144265600-144272000	Weak transcription	H9 Cell Line	embryonic stem cell
22	chr4:144265600-144276400	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
23	chr4:144265800-144270000	Enhancers	Brain Angular Gyrus	brain
24	chr4:144265800-144272000	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
25	chr4:144265800-144276400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
26	chr4:144266000-144268800	Weak transcription	Fetal Stomach	stomach
27	chr4:144266200-144268800	Enhancers	Brain Substantia Nigra	brain
28	chr4:144266200-144269000	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
29	chr4:144266200-144272200	Weak transcription	Brain Germinal Matrix	brain
30	chr4:144266400-144268800	Weak transcription	NHLF	lung
31	chr4:144266800-144269800	Enhancers	Stomach Smooth Muscle	stomach
32	chr4:144266800-144270400	Enhancers	Rectal Mucosa Donor 31	rectum
33	chr4:144266800-144272400	Weak transcription	Cortex derived primary cultured neurospheres	brain
34	chr4:144267000-144269000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
35	chr4:144267200-144269400	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
36	chr4:144267400-144268800	Enhancers	Breast Myoepithelial Primary Cells	Breast
37	chr4:144267400-144269800	Flanking Active TSS	K562	blood
38	chr4:144267400-144270200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
39	chr4:144267400-144272800	Weak transcription	Muscle Satellite Cultured Cells	--
40	chr4:144267400-144272800	Weak transcription	Osteobl	bone
41	chr4:144267600-144269000	Genic enhancers	Fetal Lung	lung
42	chr4:144267600-144270200	Enhancers	Brain Cingulate Gyrus	brain
43	chr4:144267800-144268800	Enhancers	Brain Inferior Temporal Lobe	brain
44	chr4:144267800-144268800	Weak transcription	Gastric	stomach
45	chr4:144267800-144269400	Weak transcription	Fetal Muscle Trunk	muscle
46	chr4:144267800-144269400	Weak transcription	Stomach Mucosa	stomach
47	chr4:144267800-144269600	Weak transcription	Left Ventricle	heart
48	chr4:144267800-144272200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
49	chr4:144267800-144272200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
50	chr4:144267800-144272200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links